UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                  SCHEDULE 13G

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (Amendment No. )*



                         BIO-IMAGING TECHNOLOGIES, INC.
--------------------------------------------------------------------------------
                                (Name of Issuer)



                        COMMON STOCK, $0.00025 PAR VALUE
--------------------------------------------------------------------------------
                          (Title of Class of Securities)



                                   09056N103
--------------------------------------------------------------------------------
                                 (CUSIP Number)



                               DECEMBER 31, 2001
--------------------------------------------------------------------------------
            (Date of Event Which Requires Filing of this Statement)



Check the  appropriate box to designate the rule pursuant to which this Schedule
is filed:

|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).



CUSIP No.   09056N103
          ------------

1.   Names of Reporting  Persons.  I.R.S.  Identification  Nos. of above persons
     (entities only).    Mark L. Weinstein
                      -------------------------

2.   Check the Appropriate Box if a Member of a Group (See Instructions)
     (a)
        ----------------------------------------------------------

     (b)
        ----------------------------------------------------------


3.   SEC Use Only
                  ------------------------------------------------


4.   Citizenship or Place of Organization       United States
                                            ----------------------

Number of          5. Sole Voting Power               509,337
Shares                                          ------------------
Beneficially       6. Shared Voting Power             N/A
Owned by                                        ------------------
Each               7. Sole Dispositive Power          509,337
Reporting                                       ------------------
Person With        8. Shared Dispositive Power        N/A
                                                ------------------

9.   Aggregate Amount Beneficially Owned by Each Reporting Person    509,337
                                                                   -----------

10.  Check if the  Aggregate  Amount in Row (9)  Excludes  Certain  Shares  (See
     Instructions)
                  --------------

11.  Percent of Class Represented by Amount in Row (9)    5.9%
                                                        -------

12.  Type of Reporting Person (See Instructions)          IN
                                                        -------



ITEM 1.

     (a)  Name of Issuer:

          The issuer of the  securities to which this statement
          relates is Bio-Imaging Technologies, Inc., a Delaware corporation.

     (b)  Address  of  Issuer's  Principal   Executive  Offices:

          The  issuer's   principal   executive   offices  are  located  at  826
          Newtown-Yardley Road, Newtown, Pennsylvania 18940-1721.

ITEM 2.

     (a)  Name of Person Filing:

          The filing person is Mark L. Weinstein.

     (b)  Address  of  Principal  Business  Office or, if none,  Residence:

          The principal  business  office for the filing  person is  Bio-Imaging
          Technologies,  Inc., 826 Newtown-Yardley  Road, Newtown,  Pennsylvania
          18940-1721.

     (c)  Citizenship:

          The citizenship for the filing person is United States.

     (d)  Title of Class of Securities:

          The title of the class of  securities  is common  stock,  $0.00025 par
          value.

     (e)  CUSIP Number:

          The CUSIP number is 09056N103.

ITEM 3.  IF  THIS  STATEMENT  IS  FILED  PURSUANT  TO   SS.SS.240.13D-1(B),   OR
     240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:

     Selection  of  a  filing  category  pursuant  to   ss.ss.240.13d-1(b),   or
     240.13d-2(b) or (c) is not applicable.

ITEM 4.  OWNERSHIP.

     Provide  the  following  information  regarding  the  aggregate  number and
     percentage of the class of securities of the issuer identified in Item 1.

     (a)  Amount  beneficially owned: The number of shares beneficially owned by
          Mark L.  Weinstein is 509,337.  Such number  includes  380,837  shares
          underlying  options which are  exercisable  as of December 31, 2001 or
          sixty (60) days after such date.

     (b)  Percent of class:  The percent of the class held by Mark L.  Weinstein
          is 5.9%.

     (c)  Number of shares as to which the person has:

          (i)  Sole power to vote or to direct the vote:  Mark L.  Weinstein has
               sole power to vote or to direct the vote of 509,337 shares.

          (ii) Shared  power to vote or to direct the vote:  The shared power to
               vote or to direct the vote of shares is not applicable.

          (iii)Sole power to dispose or to direct the  disposition  of:  Mark L.
               Weinstein has sole power to dispose or to direct the  disposition
               of 509,337 shares.

          (iv) Shared  power to  dispose or to direct  the  disposition  of: The
               shared power to dispose or to direct the disposition of shares is
               not applicable.

Instruction:  For computations  regarding  securities which represent a right to
acquire an underlying security see ss.240.13d-3(d)(1).



ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

If this  statement  is being filed to report the fact that as of the date hereof
the  reporting  person has ceased to be the  beneficial  owner of more than five
percent  of the class of  securities,  check  the  following  [ ].

Instruction:  Dissolution of a group requires a response to this item.

ITEM 6.  OWNERSHIP  OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER  PERSON.

The  ownership  of more than five  percent  on behalf of  another  person is not
applicable.

ITEM 7.  IDENTIFICATION  AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

The  identification  and  classification  of the  subsidiary  which acquired the
security being reported by the parent holding company is not applicable.

ITEM 8.  IDENTIFICATION  AND  CLASSIFICATION OF MEMBERS OF THE GROUP.

The notice and classification of a group is not applicable.

ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

The notice of dissolution of a group is not applicable.

ITEM 10. CERTIFICATION.

By signing  below,  I certify that, to the best of my knowledge and belief,  the
securities  referred to above were not acquired and are not held for the purpose
of or with the effect of  changing or  influencing  the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.



                                      -2-


                                    SIGNATURE

After  reasonable  inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


                                             February 14, 2002
                                        ----------------------------------
                                                  Date

                                             /s/ Mark L. Weinstein
                                        ------------------------------------
                                                  Signature


                                             Mark L. Weinstein (Stockholder)
                                        ------------------------------------
                                                  Name/Title


The  original  statement  shall be signed by each  person  on whose  behalf  the
statement is filed or his authorized representative.  If the statement is signed
on behalf of a person by his authorized  representative  other than an executive
officer  or   general   partner  of  the   filing   person,   evidence   of  the
representative's  authority to sign on behalf of such person shall be filed with
the  statement,  provided,  however,  that a power of attorney  for this purpose
which is already on file with the Commission may be  incorporated  by reference.
The name and any title of each person who signs the statement  shall be typed or
printed beneath his signature.

NOTE.  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all exhibits.  See  ss.240.13d-7  for other
parties for whom copies are to be sent.


ATTENTION: INTENTIONAL  MISSTATEMENTS  OR OMISSIONS OF FACT CONSTITUTE  FEDERAL
           CRIMINAL VIOLATIONS. (SEE 18 U.S.C. 1001).






                                      -3-